Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;24(4):e70151.
doi: 10.1111/jocd.70151.

Response to Comments on "Oral Tranexamic Acid Treats Papulopustular Rosacea by Improving the Skin Barrier"

Zining Xu  1 , Biao Yu  2 , Bingyang Xu  1 , Shuhong Ye  1 , Yuxin Qing  1 , Bin Zhao  3 , Sun Hong  4 , Na Wu  5 , Jiawen Wu  1
Affiliations

Response to Comments on "Oral Tranexamic Acid Treats Papulopustular Rosacea by Improving the Skin Barrier"

Zining Xu et al. J Cosmet Dermatol. 2025 Apr.
No abstract available

Keywords: oral; rosacea; skin barrier; tranexamic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Representative images of rosacea patients at baseline and 8 weeks following traditional or TXA treatment. Pictures of the Octaspectral Facial Imager and Clinical Images at EG Baseline and at 8w of treatment (a, c). Pictures of the Octaspectral Facial Imager and Clinical Images at CG Baseline and at 8w of treatment (b, d).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Li G. L. and Li Y. M., “Oral Tranexamic Acid Can Reduce Blood Loss After Total Knee and Hip Arthroplasty: A Meta‐Analysis,” International Journal of Surgery 46 (2017): 27–36. - PubMed
    1. Xu Z., Yu B., Xu B., et al., “Oral Tranexamic Acid Treats Papulopustular Rosacea by Improving the Skin Barrier,” Journal of Cosmetic Dermatology 23, no. 9 (2024): 2918–2926. - PubMed
    1. Woo Y. R., Kim H. S., Lee S. H., et al., “Systemic Comorbidities in Korean Patients With Rosacea: Results From a Multi‐Institutional Case‐Control Study,” Journal of Clinical Medicine 9, no. 10 (2020): 3336. - PMC - PubMed
    1. Wienholtz N. K. F., Christensen C. E., Haugaard J. H., et al., “Cohort Profile: Copenhagen Rosacea Cohort (COROCO) and Copenhagen Migraine Cohort (COMICO),” BMJ Open 10, no. 8 (2020): e039445. - PMC - PubMed
    1. Yang F., Wang L., Shucheng H., and Jiang X., “Differences in Clinical Characteristics of Rosacea Across Age Groups: A Retrospective Study of 840 Female Patients,” Journal of Cosmetic Dermatology 22, no. 3 (2023): 949–957. - PubMed

LinkOut - more resources